Monday, April 18, 2016

BRIEF-Caladrius Biosciences reaches agreement with japanese regulators for development of cell therapy

* Caladrius reaches agreement with japanese regulators on

development plan for cd34 cell therapy for critical limb

ischemia

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)